Indivior Pharmaceuticals Inc
INDV
Classificação em ações
#3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Preço da ação
$34.01
Última sincronização: 2026-10-19
Valor de mercado
$4.24B
Variação (1 dia)
4.81%
Variação (1 ano)
40.02%
País
US
Negociar Indivior Pharmaceuticals Inc (INDV)
Categoria
Healthcare
Rácio P/B de Indivior Pharmaceuticals Inc (INDV)
Rácio P/B em October 2026 TTM: -20.59
De acordo com os relatórios financeiros mais recentes e o preço das ações da Indivior Pharmaceuticals Inc, o rácio P/B atual (TTM) é -20.59. No final de 2023, o rácio P/B era 31.28.
Histórico do rácio P/B da Indivior Pharmaceuticals Inc de 2016 a 2026
Rácio P/B no final de cada ano
| Ano | Rácio P/B | Alterar |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
Rácio P/B de empresas semelhantes ou concorrentes
| Empresa | Rácio P/B | Diferença do rácio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
